BSEOmkar Pharmachem LtdMinimalNeutral
Announced Wed, 27 May · 15:34 IST

Dear Sir/Ma''am, Please find Annual Secretarial Compliance report for the year ended 31.03.2026 of Omkar Pharmachem Limited.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Omkar Pharmachem Ltd has filed its Annual Secretarial Compliance Report for the financial year ended 31 March 2026, as required under SEBI LODR Regulation 24A(2). The report was issued by Practicing Company Secretary M/s Maulik Bhavsar & Associates. The audit covered compliance with multiple SEBI regulations including LODR 2015, PIT Regulations 2015, SAST 2011, Depositories Regulations 2018, and other applicable SEBI regulations. The report states that the listed entity has complied with all applicable SEBI regulations, circulars, and guidelines. No deviations, violations, or fines were reported. No actions were taken by SEBI or Stock Exchanges against the company, its promoters, or directors during the review period. No statutory auditor resignations occurred. The company does not have any subsidiaries.

Likely market impact

Clean compliance report with no deviations — a positive signal for shareholders indicating strong adherence to SEBI regulatory requirements. No immediate stock price impact expected, though consistent clean compliance can support investor confidence.